Carlsmed, Inc. Investing Cash Flow
Carlsmed, Inc. (CARL) reported Investing Cash Flow of -$19.86 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-05
- Carlsmed, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$19.66M.
- Carlsmed, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$206.00K.
- Carlsmed, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$24.23M.
- Carlsmed, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$343.00K.
- Carlsmed, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$25.48M.
- Carlsmed, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$180.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$19.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$19.86M 10-Q · filed 2026-08-05 | -$44.09M derived: sum of 3 quarters · filed 2026-08-05 | -$44.44M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$206.00K 10-Q · filed 2026-05-05 | -$24.44M derived: sum of 2 quarters · filed 2026-05-05 | -$24.78M derived: sum of 3 quarters · filed 2026-05-05 | -$25.45M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$24.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$24.57M derived: sum of 2 quarters · filed 2026-02-25 | -$25.25M derived: sum of 3 quarters · filed 2026-08-05 | -$25.48M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$343.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.01M derived: sum of 2 quarters · filed 2026-08-05 | -$1.25M 10-Q · filed 2025-11-06 | -$1.31M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$672.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$910.00K 10-Q · filed 2026-08-05 | -$971.00K derived: sum of 3 quarters · filed 2026-08-05 | -$1.02M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$238.00K 10-Q · filed 2026-05-05 | -$299.00K derived: sum of 2 quarters · filed 2026-05-05 | -$351.00K derived: sum of 3 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$113.00K derived: sum of 2 quarters · filed 2026-02-25 | -$180.00K 10-K · filed 2026-02-25 | |
| 2024-09-30 | -$52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$119.00K 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$67.00K 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |